Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Apogee Therapeutics Inc fell by 33.28m. Cash Flow from Financing totalled 315.39m or -- of revenues. In addition the company used 74.76m for operations while cash used for investing totalled 273.91m.
Cash flow per share | -1.25 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 13.65 |
---|---|
Tangible book value per share | 13.65 |
More ▼
Balance sheet in USDView more
Current ratio | 27.70 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼